In an attempt to examine other signaling pathways and other drugs, the present study probed the NO-cGMP pathway and the effect of its modulation by the selective PDE-5A inhibitor sildenafil in cardiac hypertrophy. This evidence concerns the gene PDE5A and cardiac hypertrophy.